Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

10x Genomics, Inc. (TXG)

48.89   -0.15 (-0.31%) 03-24 11:52
Open: 48.38 Pre. Close: 49.04
High: 49.44 Low: 47.695
Volume: 111,482 Market Cap: 5,640(M)

Technical analysis

as of: 2023-03-24 10:48:20 AM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 60.85     One year: 71.07
Support: Support1: 46.63    Support2: 43.25
Resistance: Resistance1: 52.09    Resistance2: 60.85
Pivot: 48.38
Moving Average: MA(5): 48.96     MA(20): 48.34
MA(100): 41.46     MA(250): 42.28
MACD: MACD(12,26): 0.6     Signal(9): 0.6
Stochastic oscillator: %K(14,3): 69.6     %D(3): 71.1
RSI: RSI(14): 53.5
52-week: High: 83.33  Low: 23.8
Average Vol(K): 3-Month: 1,047 (K)  10-Days: 859 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ TXG ] has closed below upper band by 34.5%. Bollinger Bands are 46.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 51.59 - 51.96 51.96 - 52.24
Low: 47.94 - 48.32 48.32 - 48.6
Close: 48.56 - 49.13 49.13 - 49.57

Company Description

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Headline News

Fri, 24 Mar 2023
10x Genomics, Inc. (NASDAQ:TXG) Shares Could Be 28% Below Their Intrinsic Value Estimate - Simply Wall St

Thu, 23 Mar 2023
Analysts have given 10x Genomics, Inc. (NASDAQ:TXG) an average ... - Best Stocks

Thu, 23 Mar 2023
Allworth Financial LP Has $1.88 Million Stock Holdings in 10x ... - MarketBeat

Sun, 19 Mar 2023
Guru Fundamental Report for TXG - Nasdaq

Mon, 13 Mar 2023
10x Genomics, Inc. (NASDAQ:TXG) Shares Acquired by Two Sigma ... - MarketBeat

Thu, 02 Mar 2023
This Insider Has Just Sold Shares In 10x Genomics, Inc. (NASDAQ:TXG) - Simply Wall St

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Health Information Services
Shares Out. 96 (M)
Shares Float 93 (M)
% Held by Insiders 2.6 (%)
% Held by Institutions 99.6 (%)
Shares Short 6,110 (K)
Shares Short P.Month 7,460 (K)

Stock Financials

EPS -4.18
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 7.17
Profit Margin (%) -33.3
Operating Margin (%) -28.2
Return on Assets (ttm) -9
Return on Equity (ttm) -21.3
Qtrly Rev. Growth 4.5
Gross Profit (p.s.) 4.35
Sales Per Share 5.26
EBITDA (p.s.) -1.23
Qtrly Earnings Growth 0
Operating Cash Flow -42 (M)
Levered Free Cash Flow -65 (M)

Stock Valuations

PE Ratio -11.79
PEG Ratio 0.2
Price to Book value 6.85
Price to Sales 9.32
Price to Cash Flow -113.17

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.